reMYND NV - Product Pipeline Review - 2016
"reMYND
NV - Product Pipeline Review - 2016"
The Report covers current Market Trends, Worldwide Analysis, Global
Forecast, Review, Share, Size, Growth, Effect.
Description-
Global
Markets Directs, reMYND NV - Product Pipeline Review - 2016, provides
an overview of the reMYND NVs pharmaceutical research and development
focus.
The
report provides comprehensive information on the therapeutics under
development by reMYND NV, complete with analysis by stage of
development, drug target, mechanism of action (MoA), route of
administration (RoA) and molecule type. The report also covers the
descriptive pharmacological action of the therapeutics, its complete
research and development history and the dormant and discontinued
projects.
Global
Markets Directs report features investigational drugs from across
globe covering over 20 therapy areas and nearly 3,000 indications.
The report is built using data and information sourced from Global
Markets Directs proprietary databases, company/university websites,
clinical trial registries, conferences, SEC filings, investor
presentations and featured press releases from company/university
sites and industry-specific third party sources. Drug profiles
featured in the report undergoes periodic review following a
stringent set of processes to ensure that all the profiles are
updated with the latest set of information. Additionally, various
dynamic tracking processes ensure that the most recent developments
are captured on a real time basis.
Scope
-
The report provides a snapshot of the pipeline therapeutic landscape
of reMYND NV
-
The report provides overview of reMYND NV including its business
description, key facts, and locations and subsidiaries
-
The report features descriptive drug profiles for the pipeline
products which includes, product description, descriptive MoA, R&D
brief, licensing and collaboration details & other developmental
activities
-
The report covers pipeline products based on various stages of
development ranging from pre-registration till discovery and
undisclosed stages
-
The report assesses reMYND NVs pipeline therapeutics based on drug
target, mechanism of action (MoA), route of administration (RoA) and
molecule type
Reasons
to buy
-
Evaluate reMYND NVs strategic position with total access to detailed
information on its product pipeline
-
Gain strategically significant competitor information, analysis, and
insights to formulate effective R&D strategies
-
Identify emerging players with potentially strong product portfolio
and create effective counter-strategies to gain competitive advantage
-
Identify and understand important and diverse types of therapeutics
under development for reMYND NV
-
Identify potential new clients or partners in the target demographic
-
Plan mergers and acquisitions effectively by identifying key players
and its most promising pipeline therapeutics
-
Devise corrective measures for pipeline projects by understanding
reMYND NVs pipeline depth and focus of pipeline therapeutics
Comments
Post a Comment